Viewing Study NCT00610493


Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2025-12-25 @ 11:16 PM
Study NCT ID: NCT00610493
Status: COMPLETED
Last Update Posted: 2017-12-08
First Post: 2008-01-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
Sponsor: M.D. Anderson Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-01-25
Start Date Type: ACTUAL
Primary Completion Date: 2017-11-28
Primary Completion Date Type: ACTUAL
Completion Date: 2017-11-28
Completion Date Type: ACTUAL
First Submit Date: 2008-01-25
First Submit QC Date: None
Study First Post Date: 2008-02-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-12-06
Last Update Post Date: 2017-12-08
Last Update Post Date Type: ACTUAL